Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol vs Carvedilol for intradialytic hypotension and heart rate variability in chronic kidney disease patients on hemodialysis
TCTR20260701007Phase 1Recruiting
- Sponsor
- Lampang Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in chronic kidney disease (CKD) and intradialytic hypotension (IDH) comparing Metoprolol arm with Carvedilol arm (2 arms). Primary endpoints: Incidence of intradialytic hypotension and Heart rate variability parameters. Started Jun 2026; status: recruiting.
02
Drugs
metoprololcarvedilol
03
Conditions
chronic kidney disease (CKD)intradialytic hypotension (IDH)
Beyond the preview
Go deeper on TCTR20260701007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260701007.